Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid Stoffw Microb

Brunasso, AM; Massone, C.
Thrombocytopenia associated with the use of anti-tumor necrosis factor-alpha agents for psoriasis.
J Am Acad Dermatol. 2009; 60(5):781-785 Doi: 10.1016/j.jaad.2008.12.001
Web of Science PubMed FullText FullText_MUG

 

Führende Autor*innen der Med Uni Graz
Brunasso Vernetti Alexandra Maria
Massone Cesare
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
Thrombocytopenia has been reported to be associated with efalizumab therapy, but has only sporadically been reported with other anti-tumor necrosis factor alfa (TNF-alpha) agents. To describe the frequency of thrombocytopenia in a cohort of patients who underwent biological therapies for psoriasis. This was a retrospective observational study of 93 patients. One hundred eighteen courses of biological therapies were administered to 93 patients. Four of 67 patients who received anti-TNF-alpha agents developed drug-induced thrombocytopenia during treatment, compared with none of the 51 patients receiving efalizumab therapy. The platelet count recovered after suspension of anti-TNF-alpha agents in 3 patients and relapsed after re-exposure in two patients. The overall estimated frequency of thrombocytopenia in our cohort was 4.30% (95% confidence interval [CI], 0% to 6.2%). These findings should be validated in larger studies. Drug-induced thrombocytopenia is a potential side effect of anti-TNF-alpha agents. Immediate monitoring of platelet counts is recommended if autoimmunity is suspected.
Find related publications in this database (using NLM MeSH Indexing)
Adolescent -
Adult -
Aged -
Aged, 80 and over -
Antibodies, Monoclonal - therapeutic use
Arthritis, Psoriatic - drug therapy
Female -
Humans -
Male -
Middle Aged -
Platelet Count -
Psoriasis - drug therapy
Retrospective Studies -
Thrombocytopenia - chemically induced
Tumor Necrosis Factor-alpha - antagonists & inhibitors

Find related publications in this database (Keywords)
adalimumab
efalizumab
etanercept
infliximab
psoriasis
thrombocytopenia
© Med Uni Graz Impressum